Verastem (VSTM) Non-Current Assets (2011 - 2026)

Verastem (VSTM) recorded quarterly Non-Current Assets of $24.9 million in Q1 2026, up 8.14% quarter-over-quarter from $23.0 million in Q4 2025, and up 255.82% on a YoY basis from $7.0 million in Q1 2025.

Verastem (VSTM) Non-Current Assets (2011 - 2026) Analysis & Trends

Verastem's Non-Current Assets history runs 16 years deep, the most recent figure standing at $24.9 million for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 255.82% year-over-year to $24.9 million; the TTM figure through Mar 2026 stood at $92.7 million (up 265.14% YoY), while the FY2025 annual figure was $23.0 million, up 250.14% from the prior year.
  • Non-Current Assets was $24.9 million for Q1 2026 at Verastem, up from $23.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $24.9 million in Q1 2026 to a low of $1.7 million in Q3 2023.
  • Historically, Non-Current Assets has averaged $8.5 million across 5 years, with a median of $5.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets sank 72.25% in 2022, then soared 298.81% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $2.2 million in 2022, then surged by 176.88% to $6.0 million in 2023, then grew by 8.96% to $6.6 million in 2024, then surged by 250.14% to $23.0 million in 2025, then rose by 8.14% to $24.9 million in 2026.
  • The last three Non-Current Assets figures came in at $24.9 million (Q1 2026), $23.0 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 24.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.90 Mn
Dec 31, 2025 23.03 Mn
Sep 30, 2025 22.80 Mn
Jun 30, 2025 21.99 Mn
Mar 31, 2025 7.00 Mn
Dec 31, 2024 6.58 Mn
Sep 30, 2024 5.72 Mn
Jun 30, 2024 6.10 Mn
Mar 31, 2024 5.87 Mn
Dec 31, 2023 6.04 Mn
Sep 30, 2023 1.67 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 1.98 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 2.34 Mn
Jun 30, 2022 2.53 Mn
Mar 31, 2022 2.71 Mn
Dec 31, 2021 2.92 Mn
Sep 30, 2021 3.12 Mn
Jun 30, 2021 9.13 Mn